Filing Details
- Accession Number:
- 0001127602-10-031583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-28 14:04:58
- Reporting Period:
- 2010-12-27
- Filing Date:
- 2010-12-28
- Accepted Time:
- 2010-12-28 14:04:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1320940 | B William Hayes | 531 South Spring Street Burlington NC 27215 | Chief Financial Officer, Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-27 | 30,366 | $60.04 | 55,810 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-27 | 30,366 | $87.95 | 25,444 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2010-12-27 | 30,366 | $0.00 | 30,366 | $60.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,734 | 2010-02-10 | 2019-02-10 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The option vests in three equal annual installments beginning on the date reflected in this column. 60,734 shares remain subject to future vesting.
- Amount shown reflects a 2-for-1 stock split effective on May 10, 2002.
- Common stock purchase option granted under the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The price of $87.9504 per share represents a weighted average of sales prices ranging from $87.54 to $88.27 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or asecurity holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.